LMAT - lemaitre.com Enterprise Value

Brandmark of LeMaitre Corp (LMAT)

This daily price action for LeMaitre Vascular, Inc. (LMAT) demonstrates an Enterprise Value of 1764.08. LeMaitre Vascular, Inc. (LMAT) manufactures equipment for vascular surgeries, where high profitability and stable cash flow protect the business from market volatility. A leading position in a niche segment and physician loyalty allow the company to avoid price wars. Growth is driven by the gradual refinement of stent designs and materials.

LeMaitre - LMAT Total Company Value (period 11/23/2025 - 10/30/2026)
Manufactured product of LeMaitre Vascular Inc

LeMaitre Vascular, Inc. (LMAT) focuses on niche dominance in peripheral surgery, maintaining a conservative pace of updates to its vascular graft product line. The consolidated enterprise value, combining market capitalization and net debt, reflects the actual cost of acquiring this business while accounting for its liquidity. The price action of this consolidated enterprise value allows investors to perform a real-time assessment of the asset's true price, avoiding overpayment when purchasing the company.

Who LeMaitre Vascular, Inc. competes with

ISRG - Real Price to Acquire Entire Company|Danaher Corp - Enterprise Value|BDX - Enterprise Value|STE (STERIS plc) - Real Price to Acquire Entire Company|WST: Aggregate Business Value|Total Company Value Baxter|Real Price to Acquire Entire Company Masimo Corp (MASI)|Enterprise Value STVN|TFX - Total Enterprise Value|Enterprise Value MMSI (Merit Medical Systems)|NVST: Business Value|ICU Medical - Enterprise Value|Company Buyout Price Dentsply Sirona Inc XRAY|ATRC: Enterprise Value|Real Price to Acquire Entire Company STAAR Surgical Co|NAGE (ChromaDex Corp) - Enterprise Value|Enterprise Value zimvie.com|Total Company Value AngioDynamics (ANGO)|Total Company Value CERS (Cerus Corp.)|Alpha Teknova Inc - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash MGRM|Sharps Tech - Enterprise Value|Company Buyout Price InfuSystem Holdings INFU|Utah Medical Products, Inc. (UTMD) - Total Company Value|Business Value KRMD|Total Company Value Nyxoah, S.A.|Microbot Medical, Inc (MBOT) - Company Buyout Price|Real Price to Acquire Entire Company PDEX (Pro-Dex, Inc.)|Aggregate Business Value ZTEK|Total Company Value Elutia ELUT|Value Adjusted for Debt and Cash MLSS|NXGL: Real Price to Acquire Entire Company|RVP - Enterprise Value|Harvard Bioscience (HBIO) - Total Company Value|Real Price to Acquire Entire Company femasys.com|MHUA (Meihua Medical Technologies) - Enterprise Value|Total Enterprise Value Predictive Oncology Corp POAI|Total Company Value Callan JMB Inc (CJMB)|Atrion Corporation Inc. - Business Value|NeuroMetrix, Inc. - Real Price to Acquire Entire Company